Pictet Asset Management (Switzerland)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.34B Sell
2,577,185
-145,338
-5% -$78.4M 1.59% 3
2023
Q1
$1.57B Sell
2,722,523
-2,144
-0.1% -$1.21M 1.96% 2
2022
Q4
$1.5B Sell
2,724,667
-59,349
-2% -$31.4M 2.17% 1
2022
Q3
$1.41B Sell
2,784,016
-52,339
-2% -$29.3M 2.09% 1
2022
Q2
$1.54B Sell
2,836,355
-83,901
-3% -$46.2M 2.14% 1
2022
Q1
$1.72B Sell
2,920,256
-71,286
-2% -$41M 1.95% 1
2021
Q4
$2B Sell
2,991,542
-63,218
-2% -$39.5M 1.99% 1
2021
Q3
$1.75B Buy
+3,054,760
New +$1.68B 1.93% 1

Other funds holding TMO

Pictet Asset Management (Switzerland)'s TMO Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Thermo Fisher Scientific (TMO) stake by 5.3% in Q2 2023, selling an estimated $78.4M and leaving 2,577,185 shares worth $1.34B. The position accounts for 1.59% of the portfolio, ranked #3.

Pictet Asset Management (Switzerland) first reported a position in TMO in Q3 2021 and has held it in 8 quarters since. The position peaked at $2B in Q4 2021. 2,388 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 2,577,185 shares of Thermo Fisher Scientific worth $1.34B as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 145,338 Thermo Fisher Scientific shares in Q2 2023, an estimated $78.4M.
  • Thermo Fisher Scientific made up 1.59% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #3 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Thermo Fisher Scientific position peaked at $2B in Q4 2021.
  • 2,388 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.